The Business Research Company
The Business Research Company’s Diabetic Macular Edema Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034
— The Business Research Company
LONDON, GREATER LONDON, UNITED KINGDOM, March 25, 2025 /EINPresswire.com/ — What’s driving the growth of the Diabetic Macular Edema DME market?
The Diabetic Macular Edema DME market has sustained steady growth in recent years. Growing from $4.67 billion in 2024 to $4.89 billion in 2025, this reflects a compound annual growth rate CAGR of 4.7%. Such growth can be attributed to rising incidence of diabetes, an increase in edema-related disorders, growth in prevalence of diabetic eye diseases, a surge in the geriatric population, and an increase in blindness cases.
Looking to the future, the DME market is expected to see robust growth in the coming years. Forecasts predict it will grow to $5.82 billion in 2029, with a compound annual growth rate CAGR of 4.4%.
Get Your Free Sample Market Report:
What influences will shape the growth of the Diabetic Macular Edema DME market?
The DME market expansion can be attributed to increased access to healthcare, rising government healthcare funding, increased awareness concerning diabetic complications, and the growing adoption of telemedicine for eye care. Other influencing factors encompass the expansion of specialist diabetic eye care centres and the development of anti-VEGF therapies, adoption of corticosteroid implants, advancements in drug delivery systems, innovative retinal laser treatments, AI-powered diagnostic tools, and the adoption of minimally invasive surgical techniques.
Further, the escalating prevalence of diabetes is expected to propel growth in the Diabetes Macular Edema DME market. Factors such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, aging populations, and genetic predisposition are causing diabetes rates to spiral.
Order Your Report Now For A Swift Delivery:
Who are the key players in the Diabetic Macular Edema DME market?
Key industry players include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Novartis AG, Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, and others. These market leaders are increasingly focusing on the development of advanced drug therapies to improve patient outcomes.
How is the Diabetic Macular Edema DME Market segmented?
By Treatment:
1 Anti-VEGF Therapy
2 Corticosteroids
3 Laser Therapy
4 Surgical Intervention
By Disease Stage:
1 Early Stage
2 Moderate Stage
3 Advanced Stage
By Patient Demographics:
1 Adults
2 Elderly
3 Children
By Route Of Administration:
1 Intravitreal Injection
2 Topical
3 Systemic
By Distribution Channel:
1 Hospital Pharmacies
2 Retail Pharmacies
3 Online Pharmacies
Subsegments:
1 By Anti-VEGF Therapy: Monoclonal Antibodies, Recombinant Protein-Based Therapies
2 By Corticosteroids: Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids
3 By Laser Therapy: Focal Laser Photocoagulation, Panretinal Photocoagulation
4 By Surgical Intervention: Vitrectomy, Membrane Peeling
What are the regional insights in the Diabetic Macular Edema DME Market?
North America remains a significant player, boasting the largest market share in 2024. Europe, however, is projected to be the most rapidly growing region in the forecast period. The report also covers regions such as Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
Browse For More Similar Reports-
Diabetes Care Devices Global Market Report 2025
Artificial Intelligence in Diabetes Management Global Market Report 2025
Type 1 Diabetes Global Market Report 2025
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. You can trust in our 1,500,000 datasets, our extensive secondary research, and unique insights from industry leaders to keep you ahead of the game.
Contact us at:
The Business Research Company
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn
YouTube
Global Market Modelglobal-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Article originally published on www.einpresswire.com as Rising Diabetes Prevalence And Its Impact On Eye Health
